• See Also
  1. Yellow Fever
  2. Prevention of Vector-borne Infection
  • Mechanism
  1. Live attenuated virus Vaccine
  1. Sub-Saharan Africa
  2. Amazon basin of South America
  • Dose
  • Patient over age 9 months
  1. Dose: 0.5 ml subcutaneous every 10 years
  • Contraindications
  1. Immunocompromised Patient
    1. HIV Infection
    2. Immunosuppressive medications
  2. Pregnancy (relative contraindication)
  3. Infant under age 6 months
  4. Hypersensitivity to egg products
  • Efficacy
  1. Effective in 100% of patients for 10 years